Brief: Optinose Reports First Quarter 2022 Financial Results And Operational Updates

OptiNose

12/05/2022 12:10

May 12 (Reuters) - OptiNose Inc  OPTN.O :
    * OPTINOSE REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND
OPERATIONAL UPDATES
    * Q1 REVENUE ROSE 35 PERCENT TO $14.8 MILLION
    * EXPECTS XHANCE NET REVENUES FOR FULL YEAR OF 2022 TO BE AT
LEAST
$90 MILLION
    * EXPECTS FULL YEAR 2022 XHANCE AVERAGE NET REVENUE PER
PRESCRIPTION TO BE AT LEAST $220
    * EXPECTS TOP-LINE RESULTS FROM SECOND OF TWO CLINICAL
TRIALS
EVALUATING XHANCE AS A POTENTIAL TREATMENT FOR CHRONIC SINUSITIS
IN JUNE

Source text for Eikon:  ID:nGNX7m9PX 
Further company coverage:  OPTN.O 

 ((Reuters.Briefs@thomsonreuters.com;))